DNA
Ginkgo Bioworks Holdings Inc. Healthcare - Biotechnology Investor Relations →
Ginkgo Bioworks Holdings Inc. (DNA) closed at $10.10 as of 2026-02-02, trading 78.6% below its 200-week moving average of $47.11. This places DNA in the extreme value zone. The stock moved further from the line this week, up from -81.2% last week. The 14-week RSI sits at 38, indicating neutral momentum.
Over the past 202 weeks of data, DNA has crossed below its 200-week moving average 1 time. On average, these episodes lasted 202 weeks.
With a market cap of $612 million, DNA is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -50.0%. The stock trades at 1.0x book value.
Share count has increased 35.0% over three years, indicating dilution.
Over the past 4 years, a hypothetical investment of $100 in DNA would have grown to $6, compared to $162 for the S&P 500. DNA has returned -50.5% annualized vs 12.8% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: DNA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After DNA Crosses Below the Line?
Across 1 historical episodes, buying DNA when it crossed below its 200-week moving average produced an average return of -68.0% after 12 months (median -68.0%), compared to -8.0% for the S&P 500 over the same periods. After 24 months, the average return was -72.0% vs +19.0% for the index.
Each line shows $100 invested at the moment DNA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
DNA has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2022 | Ongoing | 202+ | 96.3% | Ongoing | -94.0% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02